-
FDA approves Sagent antibiotic
SCHAUMBURG, Ill. — The Food and Drug Administration has approved a generic antibiotic made by Sagent Pharmaceuticals, Sagent said.
The drug maker announced the approval of clindamycin injection, which the company said was the 12th product approved under its joint venture with Strides Arcolab, under which Strides is responsible for developing and supplying injectable products that Sagent markets in the United States.
The market for injectable clindamycin this year is about $65 million, according to IMS Health. -
Study: Rx oral steroids linked to severe vitamin D deficiency
NEW YORK — People taking oral steroids are twice as likely as the general population to have severe vitamin D deficiency, according to a study of more than 31,000 children and adults by scientists at Albert Einstein College of Medicine of Yeshiva University released last week.
Their findings, published in the Sept. 28 online edition of The Journal of Clinical Endocrinology and Metabolism, suggested that physicians should more diligently monitor vitamin D levels in patients being treated with oral steroids.